X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sensex Opens Flat; Sun Pharma Falls Over 9.2%
Fri, 18 Jan 09:30 am | Rini Mehta, TM Team

Asian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.6% while the Hang Seng is up 1%. The Nikkei 225 is trading up by 1.3%. US stocks advanced on Thursday as a published report that the United States was considering lifting tariffs on Chinese imports lifted investor sentiment.

Back home, India share markets opened on a flattish note with a positive bias. The BSE Sensex is trading up by 69 points while the NSE Nifty is trading up by 15 points. The BSE Mid Cap index and BSE Small Cap index opened up by 0.2% & 0.1% respectively.

Sectoral indices have opened the day on a mixed note with oil & gas stocks and bank stocks witnessing maximum buying interest. While, healthcare stocks and IT stocks have opened the day in red.

The rupee is currently trading at Rs 71.02 against the US$.

In the news from the economy. As per India Ratings and Research (Ind-Ra), Indian economy is likely to grow a tad higher at 7.5% in 2019-20 on account of steady improvement in major sectors.

According to the Central Statistics Office (CSO), the economy may clock a growth rate of 7.2% in the current financial year, up from 6.7% in the previous year.

After demonetisation and the GST implementation, the India Ratings had expected 2018-19 to be a year of quick recovery and, indeed, the recovery has been sharp with GDP growth coming in at 7.2%.

It further said GDP growth would have been even better but for the global headwinds caused by an abrupt rise in crude oil prices and strengthening of the US dollar, among other factors.

Over the past few years, private final consumption expenditure and government final consumption expenditure have been the primary growth drivers of Indian economic growth.

Ind-Ra said it believes that investments are slowly but steadily gaining traction, with gross fixed capital formation growing 12.2% in the current fiscal and projected to clock 10.3% in the next year.

But the flip side of this development is that it is primarily driven by the government capex (capital expenditure), as incremental private corporate capex has yet to revive.

It further said that due to the slowdown in private corporate and household capex, GDP growth has failed to accelerate and sustain itself close to or in excess of 8%.

Speaking of GDP growth, have a look at the latest data projecting the nominal GDP of countries by the year 2030.

India in the Pecking Order of Strongest Economies in Another Decade

As you can see in the chart, China would be by far the strongest economy in another decade. In fact, its GDP could be more than double of America's.

But that India will be a close second.

With GDP crossing 40 trillion dollars, the Indian economy will be at least a third bigger than the US.

No doubt the 40 trillion-dollar GDP will not come without some hiccups.

But once you know the stocks that could gain the most in the coming decade, you too be saying - 'Buy Indian. I am'.

Moving on to the news from pharma sector. As per an article in a leading financial daily, Aurobindo Pharma has agreed to acquire a portfolio of seven branded oncology injectable products from Spectrum Pharmaceuticals Inc.

Reportedly, the acquisition involves an upfront payment of US$160 million in cash, plus up to US$140 million on achieving regulatory and sales-based milestones. The acquisition also gives Aurobindo a branded commercial infrastructure in the US.

Acrotech Biopharma LLC, a wholly-owned subsidiary of Aurobindo Pharma USA Inc. will acquire the assets on a debt free and cash free basis.

The acquisition will help Aurobindo enter the branded oncology market with a range of products that are well recognized by the oncology community. Aurobindo Group will also acquire a well-established and experienced branded commercial infrastructure to continue commercializing these brands, the reports noted.

Spectrum, as part of its strategic shift to focus on novel oncology drug development and commercialization of its two late-stage pipeline products, carved out its commercial business inclusive of seven marketed oncology injectable products, intellectual property and commercial infrastructure for sale.

Aurobindo Pharma share price opened the day up by 0.5%.

To know more about the company, you can access to Aurobindo Pharma's Q2FY19 result analysis and Aurobindo Pharma FY18 annual report analysis on our website.

And to know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Equitymaster requests your view! Post a comment on "Sensex Opens Flat; Sun Pharma Falls Over 9.2%". Click here!

  

Stock Market Updates

SUN TV Plunges by 5%; BSE 500 Index Down 0.3% (Today's Market)

Jan 18, 2019 11:24 AM

SUN TV share price has plunged by 5% and its current market price is Rs 568. The BSE 500 is down by 0.3%. The top gainers in the BSE 500 Index are SREI INFRA FINANCE (up 3.7%) and HIND. CONSTRUCTION (up 3.6%). The top losers are SUN TV (down 5.2%) and BHARTI AIRTEL (down 5.8%).

VODAFONE IDEA Plunges by 5%; BSE 500 Index Down 0.2% (Today's Market)

Jan 18, 2019 11:16 AM

VODAFONE IDEA share price has plunged by 5% and its current market price is Rs 37. The BSE 500 is down by 0.2%. The top gainers in the BSE 500 Index are SREI INFRA FINANCE (up 4.2%) and HIND. CONSTRUCTION (up 4.1%). The top losers are VODAFONE IDEA (down 5.2%) and BHARTI AIRTEL (down 5.6%).

BHARTI AIRTEL Plunges by 5%; BSE 500 Index Down 0.2% (Today's Market)

Jan 18, 2019 11:10 AM

BHARTI AIRTEL share price has plunged by 5% and its current market price is Rs 332. The BSE 500 is down by 0.2%. The top gainers in the BSE 500 Index are SREI INFRA FINANCE (up 4.2%) and HIND. CONSTRUCTION (up 4.1%). The top losers are BHARTI AIRTEL (down 5.1%) and HSIL LTD (down 5.9%).

HIND. CONSTRUCTION Surges by 7%; BSE REALTY Index Down 0.0% (Today's Market)

Jan 18, 2019 10:54 AM

HIND. CONSTRUCTION share price has surged by 7% and its current market price is Rs 14. The BSE REALTY is down by 0.0%. The top gainers in the BSE REALTY Index is HIND. CONSTRUCTION (up 6.6%). The top losers are HOUSING DEV. INFRA (down 0.4%) and INDIABULLS REAL EST (down 0.5%).

PHILLIPS CARBON BLACK Plunges by 5%; BSE 500 Index Down 0.2% (Today's Market)

Jan 18, 2019 10:54 AM

PHILLIPS CARBON BLACK share price has plunged by 5% and its current market price is Rs 208. The BSE 500 is down by 0.2%. The top gainers in the BSE 500 Index are HIND. CONSTRUCTION (up 6.6%) and SREI INFRA FINANCE (up 4.8%). The top losers are PHILLIPS CARBON BLACK (down 5.2%) and SUN PHARMA ADV. RES. (down 8.2%).

Global Stock Market Drivers; HUL, Reliance Industries Q3FY19 Results and Top Stocks in Action Today (Today's Market)

Jan 18, 2019 Pre-Open

Global stock market drivers, Key Q3 results, oil prices, and top stocks to guide the markets today.

View More Indian Share Market News

Most Popular

Our First Bluechip Stock Recommendation in Smart Money Secrets(The 5 Minute Wrapup)

Jan 9, 2019

For the first time, we have recommended a bluechip stock in Smart Money Secrets.

3 Stocks in Super Investor Sumeet Nagar's Portfolio That You Can Buy Right Now(The 5 Minute Wrapup)

Jan 11, 2019

The reasons that make these six stocks in Sumeet Nagar's portfolio so compelling

The Biggest Trend That I'm Seeing in the Market Today(The 5 Minute Wrapup)

Jan 10, 2019

For the first time ever, a majority of Indian households, will start to benefit from stock market wealth.

My First Stock Trading Recommendation For 2019(Profit Hunter)

Jan 10, 2019

My first trading recommendation for 2019 is a bluechip auto stock. Find out everything about it right away.

A Proven Super Investor Can Lead to Great Wealth(Profit Hunter)

Jan 7, 2019

Following a super investor can certainly help build a portfolio that can create significant wealth in the long term.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Jan 18, 2019 11:33 AM

MARKET STATS